Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02808598 · ClinicalTrials.gov registry record · NA
Breast Cancer Trials Education Program
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 1,065
- Enrollment target
NCT02808598: Completed NA study, sponsored by University of California, San Diego.
NCT02808598 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 1,065 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (24% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02808598, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,065 participants
- Enrollment target
Study Summary
The purpose of this study is to test a program designed to increase African American and Hispanic American women's scientific literacy, knowledge of clinical trials, and to facilitate breast cancer clinical trial participation.
Primary Outcome
The study administered standardized psychosocial measure (Personal Health Survey) at baseline. Data were gathered to measure participants' knowledge and attitudes. The overall data from all measures were then used to evaluate the impact of the intervention, as well as what factors may have moderated and mediated that outcome. To measure changes in participations' behavior, they were immediately offered the opportunity to take part in another study that required a new consent document and collect
Interventions
- BEHAVIORAL Breast Cancer Clinical Trials Education Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,065 participants |
| Start Date | 2007-05 |
| Est. Completion | 2015-12 |
| Phase | NA |
What the finished NCT02808598 record still lists
NCT02808598 is an interventional study that assigns participants to a tested intervention. Its 1,065 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (24% lower).
The record links to 0 conditions, and to 1 intervention - of which Breast Cancer Clinical Trials Education Program is the first listed.
NCT02808598 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02808598 about?
NCT02808598 is a clinical study titled "Breast Cancer Trials Education Program". The purpose of this study is to test a program designed to increase African American and Hispanic American women's scientific literacy, knowledge of clinical trials, and to facilitate breast cancer clinical trial participation.
What is the current status of trial NCT02808598?
This trial is currently completed. It is a NA study. The enrollment target is 1,065 participants. The study started on 2007-05. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02808598?
The interventions under investigation include: Breast Cancer Clinical Trials Education Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02808598?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02808598's enrollment target sits among peer trials
1,065 97th of 2000 higher than 1,904 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04165798 · 1,065 participants
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
- NCT05520762 · 1,060 participants · NA
Hospital Airway Resuscitation Trial
- NCT05911568 · 1,060 participants
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
- NCT07140172 · 1,060 participants · NA
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia